Next-generation breast cancer screening tool

There is preliminary evidence that human hair and it’s specific cancer DNA phenotype can be used as an early predictor of tumour formation in the body.

We’re now developing a non-invasive and completely safe way of detecting early-stage breast cancer and are currently in the process of kicking off a performance study (basically, Phase 2 trials) in partnership with ARS Diagnostic Clinic in Riga, Latvia and with the help of Tartu University scientists.

We expect to start with the study within Mach 2020. The details of the study will be revealed here and on the clinic’s website. It is important to note that at this stage we’re testing 45-65 year old women, both with and without breast cancer diagnosis.

The science

The technology we’re using is based on FTIR (Fourier-transform infrared) spectroscopy i.e. we’re measuring how light interacts with specially pre-prepared human hair (we need only about 20 strings of hair, preferably cut just from the root) by splitting light (or more precisely electromagnetic radiation) into wavelengths called a spectrum. We then analyze the data looking for specific biomarkers in the measured spectrum.

Participating in the study

At this stage it is only possible to participate in the study through an appointment at ARS Diagnostic Clinic in Riga, Latvia. For booking details see here.

Please note that we are not able to share the results with the patients just yet. However, your contribution will be invaluable for the study and the future of cancer research and diagnostics.

The activities described above are part of the project “Developing a remote breast cancer screening service based on FTIR spectroscopy” funded by European Regional Development Fund through the Estonia-Latvia cross border cooperation programme Interreg Estonia-Latvia.

This website reflects the views of the author. The managing authority of the programme is not liable for how this information may be used.